STOCK TITAN

If You Invested in Nuveen Dow 30 Dynamic Overwrite (DIAX)

Financial Services · Asset Management · NYSE
Looking for the current price? See the DIAX quote & overview
$1,000 invested 1 Year Ago
$989
-1.1% total -1.6% CAGR
Bought on Aug 4, 2025 at $14.25
$1,000 invested 5 Years Ago
$819
-18.1% total -4.2% CAGR
Bought on Aug 4, 2021 at $17.22

What $1,000 or $10,000 in DIAX Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Sep 21, 2020
$1,000 $989 -1% $819 -18% $1,041 +4%
$10,000 $9,895 -1% $8,188 -18% $10,414 +4%

Based on real historical closing prices, dividend- and split-adjusted, through 2026-03-27. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for DIAX

$1,000 Investment Over Time

DIAX vs S&P 500

Year-by-Year Returns

DIAX annual performance
Year Start Price End Price Annual Return Cumulative
2020 $13.54 $15.20 +12.3% +12.3%
2021 $14.88 $17.77 +19.4% +31.2%
2022 $17.74 $15.51 -12.6% +14.5%
2023 $15.42 $14.00 -9.2% +3.4%
2024 $14.03 $15.06 +7.3% +11.2%
2025 $14.96 $15.26 +2.0% +12.7%
2026 $15.32 $14.10 -8.0% +4.1%

About Nuveen Dow 30 Dynamic Overwrite

Financial Services · NYSE

Nuveen Dow 30℠ Dynamic Overwrite Fund (NYSE: DIAX) is described as a non-diversified closed-end management investment company. According to available information, its stated investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average (DJIA). The fund seeks to do this by investing in an equity portfolio that aims to substantially replicate the price movements of the DJIA and by selling call options on a portion of the notional value of its equity portfolio.

The fund’s approach combines exposure to an equity portfolio tied to the DJIA with an options overwrite strategy. The overwrite component involves selling call options on a stated percentage of the notional value of the fund’s equity portfolio. The percentage referenced in available materials ranges from 35% to 75% of the notional value of the portfolio. This structure is intended to balance participation in equity market movements with the potential for option premium income and a focus on reduced volatility relative to the DJIA.

Fund structure and management

Nuveen Dow 30℠ Dynamic Overwrite Fund is organized as a closed-end fund. Closed-end funds issue a fixed number of shares that trade on an exchange, and their market price can differ from the net asset value (NAV) of the underlying portfolio. Materials relating to Nuveen closed-end funds note that closed-end funds frequently trade at a discount from NAV, and that at any point in time, including when shares are sold, they may be worth more or less than the purchase price or the NAV.

Nuveen is identified as the sponsor of a range of closed-end funds, with long experience managing such vehicles. Nuveen closed-end funds are described as offering exposure to various asset classes and being designed for income-focused investors seeking regular distributions. While this description applies to Nuveen’s closed-end fund platform as a whole, it provides context for how DIAX fits within a broader family of funds managed by Nuveen.

Investment objective and strategy

The fund’s stated objective is to seek attractive total return with less volatility than the DJIA. To pursue this objective, the fund invests in an equity portfolio that seeks to substantially replicate the price movements of the DJIA. In addition, the fund sells call options on a portion of the notional value of its equity portfolio, with the referenced range being 35% to 75%. This combination reflects a buy-write or overwrite approach, in which option premiums may contribute to the fund’s overall return profile and risk characteristics.

Available disclosures emphasize that there is no guarantee that investment objectives will be achieved and that all investments carry risk, including the possible loss of principal. Past performance is noted as no guarantee of future results. These cautions apply to Nuveen closed-end funds generally and to DIAX as part of that group.

Proposed merger involving DIAX

According to a press release, the Board of Trustees of Nuveen Dow 30℠ Dynamic Overwrite Fund has approved a proposal to merge the fund with other Nuveen covered call closed-end funds. The proposal contemplates combining Nuveen S&P 500 Buy-Write Income Fund (BXMX) and Nuveen Dow 30℠ Dynamic Overwrite Fund (DIAX) into Nuveen S&P 500 Dynamic Overwrite Fund (SPXX). The stated intent of the proposed mergers is to create a larger fund with lower net operating expenses and increased trading volume on the exchange for common shares.

The proposed mergers are subject to certain conditions, including necessary approval by the funds’ shareholders. The funds are expected to hold annual meetings of shareholders to consider approval of the merger proposal and to elect board members. Detailed information about the proposed mergers is expected to be provided in proxy materials to be filed with the U.S. Securities and Exchange Commission (SEC). The press release notes that investors are urged to read the solicitation materials and any other relevant documents when they become available, as they will contain important information about the merger proposal.

Risk considerations

Disclosures relating to Nuveen closed-end funds highlight several general risk considerations. All investments carry a certain degree of risk, including the possible loss of principal. There is no assurance that an investment will provide positive performance over any period of time, and there is no guarantee that investment objectives will be achieved. It is also noted that certain products and services may not be available to all entities or persons.

For closed-end funds, it is specifically noted that they frequently trade at a discount from net asset value. At any point in time, including when sold, shares may be worth more or less than the purchase price or the NAV, even after considering the reinvestment of fund distributions. Investors are encouraged in these materials to consider the objectives, risks, charges, and expenses of any fund before investing.

Relationship to Nuveen’s closed-end fund platform

Nuveen is described in the same press release as a sponsor of closed-end funds with assets under management across multiple closed-end funds. These funds are described as offering exposure to a broad range of asset classes and being designed for income-focused investors seeking regular distributions. While these statements apply to Nuveen’s closed-end fund lineup as a whole, DIAX is listed among the Nuveen closed-end funds referenced in connection with the proposed mergers.

Information about Nuveen’s closed-end funds, including annual and semi-annual reports and other regulatory filings, is described as accessible on the SEC’s website. These documents may discuss factors that affect Nuveen closed-end funds, including DIAX, and provide additional detail on investment strategies, risks, and operations.

Status and future considerations

As of the information provided, DIAX is the subject of a proposed merger into another Nuveen closed-end fund, SPXX. The proposal has been approved by the Boards of Trustees of the funds involved but remains subject to shareholder approval and other conditions. The press release emphasizes that the communication is for informational purposes only, is not a solicitation of a proxy, and does not constitute an offer of any securities for sale. It also notes that no offer of securities will be made except pursuant to a prospectus meeting applicable legal requirements.

Because the merger proposal is subject to conditions and further regulatory steps, the information provided describes a proposed transaction rather than a completed change in the fund’s structure. Investors seeking detailed and updated information about DIAX, its strategy, and the proposed merger are directed in the press release to future proxy and registration materials to be filed with the SEC.

Market Cap
$0.5B
Current Price
$14.10
View full DIAX overview

Frequently Asked Questions

Nuveen Dow 30 Dynamic Overwrite investment returns

How much would $1,000 invested in Nuveen Dow 30 Dynamic Overwrite be worth today?

If you invested $1,000 in Nuveen Dow 30 Dynamic Overwrite (DIAX) 5 years ago on 2021-08-04, your investment would be worth $819 as of 2026-03-27, representing a -18.1% total return, growing at a compounded rate of -4.2% per year (CAGR).

Has Nuveen Dow 30 Dynamic Overwrite outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare DIAX performance over available time periods.

What is Nuveen Dow 30 Dynamic Overwrite's average annual return?

The compound annual growth rate (CAGR) of DIAX over the past 5 years is -4.2%, growing at a compounded rate each year. Individual years vary significantly — DIAX's best recent year was 2021 (+19.4%) and worst was 2022 (-12.6%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.